Serological muscle loss biomarkers: an overview of current concepts and future possibilities
about
Cardiac cachexia: hic et nuncLoss of muscle mass: current developments in cachexia and sarcopenia focused on biomarkers and treatmentBiomarkers for physical frailty and sarcopenia: state of the science and future developmentsDietary supplementation of propionylated starch to domestic cats provides propionic acid as gluconeogenic substrate potentially sparing the amino acid valine.Efforts begin to sprout: publications in JCSM on cachexia, sarcopenia and muscle wasting receive attention.Muscle wasting: an overview of recent developments in basic research.Moving on up: the Journal of Cachexia, Sarcopenia and Muscle.Muscle wasting and cachexia in heart failure: mechanisms and therapies.Emerging biomarkers in heart failure and cardiac cachexiaCollagen Type III and VI Turnover in Response to Long-Term ImmobilizationEffects of a One-Year Physical Activity Program on Serum C-Terminal Agrin Fragment (CAF) Concentrations among Mobility-Limited Older Adults.More than osteoporosis: age-specific issues in bone health.Isotopic decay of urinary or plasma 3-methylhistidine as a potential biomarker of pathologic skeletal muscle loss.Irisin - a myokine potentially bridging muscle and fat tissue in cachexia.Neo-epitope Peptides as Biomarkers of Disease Progression for Muscular Dystrophies and Other Myopathies.Serum miRNAs miR-23a, 206, and 499 as Potential Biomarkers for Skeletal Muscle Atrophy.Detection of muscle wasting in patients with chronic heart failure using C-terminal agrin fragment: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF).Sixteen weeks of resistance training decrease plasma heat shock protein 72 (eHSP72) and increase muscle mass without affecting high sensitivity inflammatory markers' levels in sarcopenic men.Sarcopenia: assessment of disease burden and strategies to improve outcomes.CBP and P300 regulate distinct gene networks required for human primary myoblast differentiation and muscle integrity
P2860
Q26744140-76DE65AE-0383-4E64-94F0-D03CCDF7BC76Q26775254-4113E787-2779-4006-8571-852BD137976FQ26775328-D388E742-68A3-42E0-B366-F57F34EFBB4AQ34125728-A8B634A3-4AD3-4EC3-B218-BFEC0643430DQ34156932-811330B3-FE7C-4F7C-855C-5902431C60F8Q34156942-57D014FC-ECE6-4F86-BB7B-572BDFA5BC15Q34495485-0935BCCF-BE20-42E4-9D5E-49B0A9AEF202Q34681621-8B223509-07F3-4D2B-A1BE-26C387E0F9F9Q34836097-B07C6401-3F4F-4E76-820E-2A9550185364Q35862226-1AAC2DAE-B0C7-433B-A147-AA6AAF6A0C6CQ36380725-C87F20AB-956B-4258-A8EA-AAA93485A549Q36877351-1CA2DD04-E43B-435A-8B45-FD9CF745FD55Q37635905-9A0EE7D4-D601-48DC-B326-E03FA37CD581Q41940135-FFACBBF7-092C-4BBF-B664-B6A89295CEEEQ42363358-7C44EA14-7217-45CA-9C35-CF4CD387B832Q47109605-650DD891-F9DD-4A98-BCE1-3E163C3496A3Q52861755-D7984DD3-4AAC-443B-BB04-4612BA79BADEQ53415123-3452ACA1-BFB8-4488-86F6-765BA6C4F909Q55022891-DD586039-D4F1-4E90-B8C5-580E5F17BAC9Q58721602-B4130679-A024-4F9C-80A6-D9A36F239816
P2860
Serological muscle loss biomarkers: an overview of current concepts and future possibilities
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Serological muscle loss biomar ...... cepts and future possibilities
@ast
Serological muscle loss biomar ...... cepts and future possibilities
@en
type
label
Serological muscle loss biomar ...... cepts and future possibilities
@ast
Serological muscle loss biomar ...... cepts and future possibilities
@en
prefLabel
Serological muscle loss biomar ...... cepts and future possibilities
@ast
Serological muscle loss biomar ...... cepts and future possibilities
@en
P2093
P2860
P1476
Serological muscle loss biomar ...... cepts and future possibilities
@en
P2093
Anders Nedergaard
Kim Henriksen
Morten A Karsdal
P2860
P2888
P356
10.1007/S13539-012-0086-2
P50
P577
2012-09-21T00:00:00Z